title: No evidence for GADL1 variation as a bipolar disorder susceptibility factor in a Caucasian lithium-responsive cohort.
authors.affiliation: From the McGill Group for Suicide Studies, Douglas Mental Health Institute, McGill University, Montreal; the Montreal Neurological Institute and Hospital, McGill University, Montreal; and the Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
authors.forename: Cristiana
authors.initials: C
authors.lastname: Cruceanu
authors.forename: Martin
authors.initials: M
authors.lastname: Alda
authors.forename: Patrick A
authors.initials: PA
authors.lastname: Dion
authors.forename: Gustavo
authors.initials: G
authors.lastname: Turecki
authors.forename: Guy A
authors.initials: GA
authors.lastname: Rouleau
mesh_terms: D000483:Alleles; D018692:Antimanic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy / Q000235:genetics*; D002262:Carboxy-Lyases / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D044465:White People
chemical_list: D018692:Antimanic Agents; D008094:Lithium; D002262:Carboxy-Lyases; C585765:GADL1 protein, human